Emily Warner

Emily is a dedicated scientist with a rich and diverse background in molecular research and scientific outreach. Emily’s PhD explored the impact of flavonoid metabolites on endothelial function and vascular inflammation. Following her academic pursuits in diabetes at UEA and cardiovascular medicine at the University of Cambridge, Emily transitioned into pivotal roles at ikarovec, bringing her expert know-how of laboratory establishment, management, and leadership with a wealth of experience across the scientific spectra to develop and test novel gene therapies for common ophthalmic diseases.